Physician profile
Daniel L Wooster
NPI 1518960756
$2,198.77
in general payments reported to CMS, 2019-2025
34 companies · $22.72 in 2025
The $22.72 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $171 · 2021: $375 · 2022: $349 · 2023: $710 · 2024: $366 · 2025: $22.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $332.72 | 2020-2024 | Ubrelvy, Qulipta |
| Abbott Laboratories | $202.79 | 2022-2025 | Freestyle Libre 3 |
| Pfizer INC. | $186.14 | 2019-2024 | |
| Glaxosmithkline, LLC. | $180.40 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $135.22 | 2019-2023 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $119.36 | 2019-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $114.02 | 2019-2023 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $112.74 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $63.09 | 2019-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $59.73 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $53.64 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $43.75 | 2021 | |
| Nevro Corp. | $43.04 | 2021 | |
| Nobel Biocare USA | $42.80 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $41.61 | 2019-2023 | Farxiga |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $40.63 | 2024 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $40.25 | 2021-2022 | |
| Alk-Abello, INC | $40.06 | 2019-2023 | Odactra, Grastek, Ragwitek |
| Astellas Pharma US INC | $40.05 | 2021-2023 | Myrbetriq, Veozah |
| Merck Sharp & Dohme LLC | $29.26 | 2021-2023 | Belsomra |
| Sumitomo Pharma America, INC. | $29.24 | 2024 | Gemtesa |
| Exact Sciences Corporation | $28.98 | 2023-2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $27.55 | 2020-2022 | |
| Alkermes, INC. | $22.79 | 2021 | |
| Eisai INC. | $19.93 | 2024 | |
| Esperion Therapeutics, INC. | $19.54 | 2021 | |
| Amarin Pharma, INC. | $18.91 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.33 | 2022 | |
| Allergan, INC. | $17.82 | 2019 | |
| Idorsia Pharmaceuticals US INC | $16.99 | 2024 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.84 | 2024 | Xifaxan |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.66 | 2024 | Caplyta |
| Althera Pharmaceuticals LLC | $13.35 | 2021 | |
| Bardy Diagnostics, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wooster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.